Peter UGHACHUKWU, Paul OKONKWO, John OGAMA, Prince UNEKWE

Effect of methylprednisolone injection on interleukin-4 and interferon-gamma expression following hepatitis B vaccination in mice

Background/aim:The prevalence of hepatitis B infection is high worldwide with liver cirrhosis and hepatocellular carcinoma as important complications. Immunosuppression, especially from corticosteroids, is often cited as a cause of poor immune response and there is documented evidence of irrational administration of glucocorticoids to children and adults. Decreased expression of interleukin-4 and interferon-gamma is an indication of poor humoral and cellular immune responses, respectively. Therefore, we decided to find out if methylprednisolone injection decreases interleukin-4 and interferon-gamma expression following hepatitis B vaccination in mice. Materials and methods: Mice were randomly divided into 2 groups. Daily intramuscular injections of methylprednisolone (15 mg/ kg) were given to the test group while water for injection (0.1 mL) was given to the control group for 30 days. On day 6 all mice were given 2 µg of hepatitis B vaccine and they received a booster dose on day 27. On day 34, blood samples were collected and analyzed for interleukin-4 and interferon-gamma titers. Results: There was positive interleukin-4 and interferon-gamma response in all groups but the differences in titers were not statistically significant. Conclusion: At the dosages and length of exposure used in this study, methylprednisolone injection did not significantly inhibit interleukin-4 and interferon-gamma expression following immunization against hepatitis B virus in mice.

PDF

___

1. MacKeller DA, Valleroy LA, Sekura GM. Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Pub Health 2001; 91: 965-971.
2. World Health Organization. Hepatitis B. WHO Fact Sheet No. 204. Geneva, Switzerland: WHO; 2000.
3. Bukbuk DN, Bassi AP, Mangoro ZM. Sero-prevalence of hepatitis B surface antigen among primary school pupils in rural Hawal Valley, Borno State, Nigeria. Journal of Community Medicine and Primary Health Care 2005; 17: 20-23.
4. Cheng MH, Jean KT. Viruses and Human Cancers: From Basic Science to Clinical Prevention. Heidelberg, Germany: Springer; 2014.
5. World Health Organization. Global Alert and Response: Hepatitis B. Geneva, Switzerland: WHO; 2002.
6. Brown SD, Hancock JM. The mouse genome. Genome Dyn 2006; 2: 33-45.
7. Institute for Laboratory Animal Research. Guide for the Care and Use of Laboratory animals. Washington DC, USA: National Academies Press; 1996.
8. National Research Council. Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research. Washington DC, USA: National Academies Press; 2003.
9. Youm JW, Wom YS, Jeon JH, Moon KB, Kim HC, Shin KS, Young H, Kim HS. Antibody responses in mice stimulated by various doses of the potato-derived major surface antigen of hepatitis B virus. Clin Vaccine Immunol 2010; 17: 2029-2032.
10. Lauridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infec Dis 2011; 53: 68-75.
11. Garguilo S, Greco A, Gramazini M, Esposito S, Affuso A, Brunette A, Vesce G. Mice anesthesia, analgesia, and care, Part 1: anesthetic considerations in preclinical research. ILAR J 2012; 53: E55-69.
12. Hoff J. Methods of blood collection in the mouse. Lab Animal 2000; 29: 47-53.
13. Dhabhar FS. Enhancing versus suppressive effects of stress on immune function: Implications for immunoprotection and pathology. Neuromodulation 2009; 16: 300-317.
14. Franchimont D, Galon J, Gadina M, Visconti R, Zhou YJ, Aringer M, Frucht DM, Chrousos GP, OShea JJ. Inhibition of Th1 responses by glucocorticoids: dexamethasone selectively inhibits IL-12 induced STAT-4 phosphorylation in T lymphocytes. J Immunol 2000; 164: 1768-1774.
15. Remelts HHF, Meijvis SCA, Rijkers GT. Dexamethasone down-regulates the systemic cytokine response in patients with community acquired pneumonia. Clin Vaccine Immunol 2012; 19: 1532-1538.
16. Mazzocca AD, McCarthy MB, Intravia J, Beitzel K, Apostolakos J, Cote MP, Bradley J, Arciero RA. An in vitro evaluation of the anti-inflammatory effects of platelet-rich plasma, ketorolac, and methylprednisolone. Arthroscopy 2013; 29: 675-683.
17. El-Radhi A, Hogg C, Bungre J, Bush A, Corrigan C. Effect of oral glucocorticoid on serum inflammatory markers in acute asthma. Arch Dis Child 2000; 83: 158-162.
18. Schacke H, Rehwinkel H, Asadullah K. Dissociated glucocorticoid receptor ligands: compounds with an improved therapeutic index. Curr Opin Investig Drug 2005; 6: 503-507.
19. Newton R, Holden NS. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor. Mol Pharmacol 2007; 72: 799-809.
20. Silverman MN, Pearce BD, Biron CA, Miller AH. Immune modulation of the hypothalamic pituitary adrenal (HPA) axis during viral infection. Viral Immunol 2005; 18: 41-78.
21. Chen YF, Wu ZM, Xie C, Bai S, Zhao LD. Expression level of IL-6 secreted by bone marrow stromal cells in mice with aplastic anaemia. ISRN Haematology 2013; 2013: 986219.
22. Chuai X, Chen H, Wang W, Deng Y, Wen B. Alum-mixed adjuvant priming enhances HBV subunit vaccine-induced immunity in mice when combined with recombinant adenoviral-based HBV boosting. PLoS ONE 2013; 8: e54126.
23. Qin W, Jing J, Chen Q, Yang N, Wang Y, Wei X, Ou R. CpG ODN enhances immunization effects of hepatitis B vaccine in aged mice. Cell Mol Immunol 2004; 1: 148-152.